Venture-Backed Startups
101,671 companies with verified investor relationships.
0 investors
0 investors
BioLattice develops engineered cornea tissue as an alternative to donor cornea for patients with corneal blindness and those waiting for transplants. The company focuses on tissue engineering to address the shortage of donor cornea supply in the global ophthalmology market.
2 investors
1 investor
Bioledger provides traceability and compliance software for sustainable biofuels, serving farmers, waste collectors, traders, and biofuel producers across the US, EU, and other regions. The platform digitizes mass balance tracking and supply chain documentation to meet US and EU regulatory requirements.
1 investor
0 investors
0 investors
Bioliberty develops the Lifehub Clinic system, combining soft robotic wearables, gamified therapy, and AI insights to help clinicians deliver physical and occupational therapy to patients recovering from mobility issues such as stroke. The system is built for inpatient and outpatient care settings, supporting patient movement and strength training.
3 investors
0 investors
BioLife Solutions provides biopreservation media, cell culture optimization products, storage systems, and closed-system manufacturing solutions for cell and gene therapy development and production. The company serves bioprocess engineers, therapy developers, and contract development and manufacturing organizations (CDMOs) navigating clinical trials and commercial-scale manufacturing.
1 investor
Biolinco provides a platform for cell line development that uses DNA barcoding and multi-omic characterization to help biopharmaceutical companies evaluate and select optimal cell clones. The platform addresses limitations in traditional workflows that evaluate only a small number of clones.
1 investor
ηΎζη§ (Biolink) develops and manufactures process equipment and consumables for biopharmaceutical production, covering upstream cell culture, single-use fluid storage, and downstream chromatography, filtration, and hydration products. It serves China's vaccine, antibody drug, cell therapy, gene therapy, and recombinant protein industries with process development and supply-chain solutions.
1 investor
Biolinq develops a non-invasive glucose sensor that uses light to display glucose levels in real time, while also tracking activity and sleep to provide personalized health insights via a mobile app.
4 investors
BioLite makes consumer energy products, including portable power, lighting, and charging devices, and an upcoming home energy backup system for households. Through its "Energy For All" program, a portion of each sale funds access to safe lighting and charging for people living in energy poverty.
2 investors
0 investors
Biologica produces stage-specific effervescent multivitamin drinks formulated for women's hormonal health at different life stages. The products combine vitamins, minerals, probiotics, and electrolytes to address both acute hormonal symptoms and overall wellness across brain, heart, bones, and muscles.
3 investors
0 investors
BIOS develops a Universal Neural Interface, a brain-computer interface that connects directly to the peripheral nervous system to enable communication between the brain and robotic limbs or digital devices. Its first application targets individuals with limb loss, with broader potential in prosthetics.
1 investor
BiologicsMD develops recombinant fusion proteins targeting parathyroid hormone receptors for hair loss, bone disorders, and oncology treatments. The company's technology uses a dual-domain approach to localize therapeutics to disease sites with minimal off-target effects.
3 investors
Biologics Modular designs and manufactures cGMP modular clean room facilities based on intermodal container platforms, including biorepositories, biomanufacturing suites, and research clinics. It serves health science service providers, educational facilities, and pharmaceutical manufacturers with portable, scalable, pre-validated production facilities that fit inside new or existing warehouse spaces.</parameter> <parameter name="founders">[]
0 investors
0 investors
Biologos is a custom biologics contract manufacturer producing GMP-compliant, ISO 13485:2016 certified products such as cell culture media (e.g. DMEM) and buffers (e.g. Tris Buffer). It serves cell and gene therapy, biopharma, diagnostics, tissue processing, and CDMO/CMO customers.
1 investor
AI platform designing antibodies with new capabilities to cure disease.
3 investors
1 investor